Regeneron Pharmaceuticals, Inc.
NASDAQRegeneron reports Tuesday with short interest edging lower and analysts raising price targets. Put-call ratio signals moderating hedging demand versus recent weeks. Short interest in REGN stood at 2.48 million shares as of April 23, representing 2.46% of the free float. The position declined 2.2% over the past week and ticked down 0.08%…
Snapshot as of 10 May 2026
Regeneron reports Tuesday with short interest edging lower and analysts raising price targets. Put-call ratio signals moderating hedging demand versus recent weeks. Short interest in REGN stood at 2.48 million shares…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for REGN — free to start on ORTEX.
Sign up for free →Open REGN on ORTEX